Atc. Chan et al., IN-VITRO UPTAKE OF BROMODEOXYURIDINE BY HUMAN NASOPHARYNGEAL CARCINOMA (NPC) AND ITS RELATION TO CLINICAL FINDINGS, European journal of cancer. Part B, Oral oncology, 32B(1), 1996, pp. 50-54
A cell kinetic study of 27 newly diagnosed patients with nasopharyngea
l carcinoma (NPC) using the in vitro bromodeoxyuridine (BrdU) techniqu
e was performed. The results were reproducible as demonstrated by thre
e independent sections performed on each patient. No correlation betwe
en BrdU labelling index (LI) and Ho's clinical staging was found. A hi
gher LI was associated with the development of distant metastases (P =
0.057). Statistically significant correlation was found between low L
I and longer duration required to achieve complete remission in the pr
imary site of disease (P = 0.026). This study suggests a potential rol
e for in vitro BrdU labelling index as a prognosticator for NPC prior
to treatment.